News

Home
Clinical Trials
Hypermutant-Cancers-Study-Update-June-2022

Hypermutant-Cancers-Study-Update-June-2022

Want more ANZCHOG news?

View more news

Join our newsletter

"*" indicates required fields

Full Name*

Email*

Phone

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org |

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi.

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.

© 2025 ANZCHOG
Sitemap
Terms Of Use
Privacy Policy
Site by Squeeze Creative